Clinigence Holdings, Inc. is  a company focused on the population health data analytics and services markets. Our primary mission is the expansion of our subsidiaries. 

ATLANTA, GA − (BUSINESSWIRE) – October 31, 2019 – Clinigence Holdings, Inc. (“Clinigence” or the “Company”) announced today that it has become a publicly-traded company via a reverse merger with iGambit, Inc. (“iGambit”) (OTC: IGMB), a fully reporting public company.  The combined company will be called Clinigence Holdings, Inc. and will trade on the OTC Markets under the symbol CLNH. 


​Read More